Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients

Table 4 Comparison of glucose exposure, inflammation, and CV comorbidity among non-DM PD patients categorized according to each criterion of metabolic syndrome

	Triglyceride		High density lipoprotein		Hypertension		Body mass index		Glucose
	−	+	−	+	−	+	−	+	−	+
	69	69	52	86	22	116	113	25	94	44
CRP (mg/dL)	1.0 ± 2.6	1.2 ± 2.3	1.0 ± 2.4	1.2 ± 2.5^*	2.0 ± 3.7	1.0 ± 2.1^*	0.9 ± 2.0	2.0 ± 3.7^*	1.0 ± 2.1	1.4 ± 3.0^*
VFA (cm²/[kg/m²])	3.1 ± 1.8	4.6 ± 1.9^*	3.2 ± 1.8	4.2 ± 2.0^*	4.6 ± 2.0	3.7 ± 2.0	3.5 ± 1.8	5.4 ± 1.9^*	3.6 ± 2.1	4.4 ± 1.8^*
Cardiothoracic ratio (%)	48 ± 6	49 ± 7	48 ± 6	49 ± 7	47 ± 7	49 ± 7	48 ± 7	50 ± 5	48 ± 7	50 ± 7
Albumin (g/dL)	3.9 ± 0.3	4.1 ± 0.3^*	3.9 ± 0.4	4.1 ± 0.3^*	4.0 ± 0.3	4.0 ± 0.4	4.0 ± 0.3	4.1 ± 0.4	4.0 ± 0.3	4.1 ± 0.4
Renal KT/V	0.21 ± 0.32	0.19 ± 0.32	0.30 ± 0.37	0.14 ± 0.28^*	0.10 ± 0.16	0.22 ± 0.34^*	0.17 ± 0.29	0.32 ± 0.44^*	0.20 ± 0.32	0.21 ± 0.32
Glucose load (g/dL)	1.88 ± 0.33	1.86 ± 0.31	1.80 ± 0.29	1.91 ± 0.33	1.82 ± 0.31	1.88 ± 0.32	1.86 ± 0.32	1.89 ± 0.34	1.87 ± 0.33	1.85 ± 0.29
Glucose exposure (kg/year)	56 ± 20	53 ± 19	49 ± 19	58 ± 20^*	53 ± 12	55 ± 21	54 ± 20	57 ± 21	55 ± 20	53 ± 19
CAD History	7	7	3	11	3	11	12	2	8	6
CVD Event	5	5	3	7	1	9	8	2	7	3

*P < 0.05 compared by student t-test, non-parametric t-test, or Chi-test.
CAD coronary artery disease, CRP C-reactive protein, CVD cardiovascular disease.

ISSN: 1475-2840